09.12.24 -- Modernizing CAR-T Manufacturing: Is Point Of Care The Future?

The complexity of manufacturing AAV products, coupled with the challenges linked to controlling their costs, underscore the importance of improving the efficiency and scalability of these processes.

Learn about a partnership between two companies to model the costs and benefits of increasing digital maturity for mAb processes in a biopharma plant utilizing single-use technology.

Advanced therapies present challenges when it comes to scaling up production. Explore how collaboration, investment in R&D, and process optimization are paving the way for new treatment options.

For many applications, cutting-edge centrifugation technologies can achieve cell harvest optimization, providing a low-shear, high-yield process that is tightly controlled and highly reproducible.

Explore the challenges of liquid handling in cell and gene therapy processes as well as innovative solutions to simplify aliquoting in modern bioprocesses.

mRNA therapeutics have the potential to address a variety of diseases, and understanding mRNA molecules and accessing faster analytical solutions is crucial for their rapid development.

Review several challenges presented by the residues left behind by disinfectant solutions in cleanrooms, as well as effective strategies for their management.

The delivery of this mobile cGMP cleanroom facility to ACT showcases Germfree’s commitment to providing innovative solutions that meet clients' unique needs and contribute to advancing healthcare.

Here, we demonstrate the use of dielectric spectroscopy tools for monitoring the expansion and differentiation of hiPSC aggregates in stirred-tank bioreactors.

The success of this experiment shows how the integration of Process Analytical Technology probes into bioreactors can enhance process understanding and enable precise bioprocess monitoring and control.

What are viral-based vectors and why are reproducible quantitation of gene expression important in gene therapy? Get the answer to these questions, here.